nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Convulsion—Prednisolone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Milnacipran—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Milnacipran—Hypertension—Prednisolone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Milnacipran—Fatigue—Mitoxantrone—multiple sclerosis	0.00177	0.00177	CcSEcCtD
Milnacipran—Constipation—Mitoxantrone—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Milnacipran—Diarrhoea—Azathioprine—multiple sclerosis	0.00174	0.00174	CcSEcCtD
Milnacipran—Hallucination—Prednisone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Milnacipran—Syncope—Triamcinolone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Milnacipran—Syncope—Methylprednisolone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Milnacipran—Connective tissue disorder—Prednisone—multiple sclerosis	0.0017	0.0017	CcSEcCtD
Milnacipran—Neutropenia—Methotrexate—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Milnacipran—Dysuria—Methotrexate—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Milnacipran—Dizziness—Azathioprine—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Milnacipran—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00168	0.00168	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Milnacipran—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Milnacipran—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00167	0.00167	CcSEcCtD
Milnacipran—Shock—Prednisolone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Milnacipran—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Milnacipran—Convulsion—Triamcinolone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Milnacipran—Tachycardia—Prednisolone—multiple sclerosis	0.00165	0.00165	CcSEcCtD
Milnacipran—Convulsion—Methylprednisolone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Milnacipran—Hypertension—Triamcinolone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Milnacipran—Hypertension—Methylprednisolone—multiple sclerosis	0.00164	0.00164	CcSEcCtD
Milnacipran—Urticaria—Mitoxantrone—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Milnacipran—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Milnacipran—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Milnacipran—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00163	0.00163	CcSEcCtD
Milnacipran—Vomiting—Azathioprine—multiple sclerosis	0.00162	0.00162	CcSEcCtD
Milnacipran—Eye disorder—Prednisone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Milnacipran—Anxiety—Methylprednisolone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Milnacipran—Rash—Azathioprine—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Milnacipran—Dermatitis—Azathioprine—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Milnacipran—Flushing—Prednisone—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Milnacipran—Headache—Azathioprine—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Milnacipran—Dry mouth—Triamcinolone—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Milnacipran—Angiopathy—Prednisone—multiple sclerosis	0.00157	0.00157	CcSEcCtD
Milnacipran—Syncope—Dexamethasone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Milnacipran—Syncope—Betamethasone—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Milnacipran—Infection—Triamcinolone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Milnacipran—Infection—Methylprednisolone—multiple sclerosis	0.00154	0.00154	CcSEcCtD
Milnacipran—Haematuria—Methotrexate—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Milnacipran—Shock—Triamcinolone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Milnacipran—Insomnia—Prednisolone—multiple sclerosis	0.00153	0.00153	CcSEcCtD
Milnacipran—Shock—Methylprednisolone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Milnacipran—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Milnacipran—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Milnacipran—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Milnacipran—Loss of consciousness—Betamethasone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Milnacipran—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Milnacipran—Paraesthesia—Prednisolone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Milnacipran—Tachycardia—Triamcinolone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Milnacipran—Mental disorder—Prednisone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Milnacipran—Nausea—Azathioprine—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Milnacipran—Tachycardia—Methylprednisolone—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Milnacipran—Skin disorder—Methylprednisolone—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Milnacipran—Malnutrition—Prednisone—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Milnacipran—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Milnacipran—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.0015	0.0015	CcSEcCtD
Milnacipran—Convulsion—Betamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Milnacipran—Convulsion—Dexamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Milnacipran—Hypertension—Betamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Milnacipran—Hypertension—Dexamethasone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Milnacipran—Asthenia—Mitoxantrone—multiple sclerosis	0.00148	0.00148	CcSEcCtD
Milnacipran—Anxiety—Dexamethasone—multiple sclerosis	0.00146	0.00146	CcSEcCtD
Milnacipran—Anxiety—Betamethasone—multiple sclerosis	0.00146	0.00146	CcSEcCtD
Milnacipran—Hypotension—Methylprednisolone—multiple sclerosis	0.00145	0.00145	CcSEcCtD
Milnacipran—Hepatitis—Methotrexate—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Milnacipran—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00142	0.00142	CcSEcCtD
Milnacipran—Vision blurred—Prednisone—multiple sclerosis	0.00142	0.00142	CcSEcCtD
Milnacipran—Urethral disorder—Methotrexate—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Milnacipran—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00141	0.00141	CcSEcCtD
Milnacipran—Insomnia—Triamcinolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Milnacipran—Insomnia—Methylprednisolone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Milnacipran—Infection—Dexamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Milnacipran—Infection—Betamethasone—multiple sclerosis	0.0014	0.0014	CcSEcCtD
Milnacipran—Paraesthesia—Triamcinolone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Milnacipran—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Milnacipran—Shock—Betamethasone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Milnacipran—Shock—Dexamethasone—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Milnacipran—Dyspnoea—Triamcinolone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Milnacipran—Nervous system disorder—Betamethasone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Milnacipran—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Milnacipran—Agitation—Prednisone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Milnacipran—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Milnacipran—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00138	0.00138	CcSEcCtD
Milnacipran—Tachycardia—Betamethasone—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Milnacipran—Tachycardia—Dexamethasone—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Milnacipran—Dyspepsia—Triamcinolone—multiple sclerosis	0.00137	0.00137	CcSEcCtD
Milnacipran—Erythema multiforme—Methotrexate—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Milnacipran—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Milnacipran—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Milnacipran—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00136	0.00136	CcSEcCtD
Milnacipran—Eye disorder—Methotrexate—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Milnacipran—Syncope—Prednisone—multiple sclerosis	0.00135	0.00135	CcSEcCtD
Milnacipran—Anorexia—Dexamethasone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Milnacipran—Anorexia—Betamethasone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Milnacipran—Urticaria—Prednisolone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Milnacipran—Cardiac disorder—Methotrexate—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Milnacipran—Fatigue—Triamcinolone—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Milnacipran—Fatigue—Methylprednisolone—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Milnacipran—Loss of consciousness—Prednisone—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Milnacipran—Hypotension—Dexamethasone—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Milnacipran—Hypotension—Betamethasone—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Milnacipran—Angiopathy—Methotrexate—multiple sclerosis	0.00131	0.00131	CcSEcCtD
Milnacipran—Vomiting—Mitoxantrone—multiple sclerosis	0.00131	0.00131	CcSEcCtD
Milnacipran—Convulsion—Prednisone—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Milnacipran—Mediastinal disorder—Methotrexate—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Milnacipran—Hypertension—Prednisone—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Milnacipran—Rash—Mitoxantrone—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Milnacipran—Dermatitis—Mitoxantrone—multiple sclerosis	0.0013	0.0013	CcSEcCtD
Milnacipran—Chills—Methotrexate—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Milnacipran—Headache—Mitoxantrone—multiple sclerosis	0.00129	0.00129	CcSEcCtD
Milnacipran—Anxiety—Prednisone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Milnacipran—Insomnia—Dexamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Milnacipran—Insomnia—Betamethasone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Milnacipran—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Milnacipran—Paraesthesia—Betamethasone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Milnacipran—Paraesthesia—Dexamethasone—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Milnacipran—Mental disorder—Methotrexate—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Milnacipran—Malnutrition—Methotrexate—multiple sclerosis	0.00126	0.00126	CcSEcCtD
Milnacipran—Hypersensitivity—Prednisolone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Milnacipran—Dyspepsia—Betamethasone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Milnacipran—Dyspepsia—Dexamethasone—multiple sclerosis	0.00124	0.00124	CcSEcCtD
Milnacipran—Urticaria—Triamcinolone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Milnacipran—Urticaria—Methylprednisolone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Milnacipran—Dysgeusia—Methotrexate—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Milnacipran—Body temperature increased—Triamcinolone—multiple sclerosis	0.00123	0.00123	CcSEcCtD
Milnacipran—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Milnacipran—Decreased appetite—Dexamethasone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Milnacipran—Decreased appetite—Betamethasone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Milnacipran—Nausea—Mitoxantrone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Milnacipran—Infection—Prednisone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00122	0.00122	CcSEcCtD
Milnacipran—Fatigue—Dexamethasone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Milnacipran—Fatigue—Betamethasone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Milnacipran—Shock—Prednisone—multiple sclerosis	0.00121	0.00121	CcSEcCtD
Milnacipran—Nervous system disorder—Prednisone—multiple sclerosis	0.0012	0.0012	CcSEcCtD
Milnacipran—Tachycardia—Prednisone—multiple sclerosis	0.0012	0.0012	CcSEcCtD
Milnacipran—Skin disorder—Prednisone—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Milnacipran—Hyperhidrosis—Prednisone—multiple sclerosis	0.00119	0.00119	CcSEcCtD
Milnacipran—Vision blurred—Methotrexate—multiple sclerosis	0.00118	0.00118	CcSEcCtD
Milnacipran—Anorexia—Prednisone—multiple sclerosis	0.00117	0.00117	CcSEcCtD
Milnacipran—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Milnacipran—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00115	0.00115	CcSEcCtD
Milnacipran—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Milnacipran—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00114	0.00114	CcSEcCtD
Milnacipran—Leukopenia—Methotrexate—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Urticaria—Dexamethasone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Urticaria—Betamethasone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Dizziness—Prednisolone—multiple sclerosis	0.00112	0.00112	CcSEcCtD
Milnacipran—Asthenia—Triamcinolone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Abdominal pain—Betamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Body temperature increased—Dexamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Abdominal pain—Dexamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Body temperature increased—Betamethasone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Asthenia—Methylprednisolone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Insomnia—Prednisone—multiple sclerosis	0.00111	0.00111	CcSEcCtD
Milnacipran—Paraesthesia—Prednisone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Pruritus—Triamcinolone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Pruritus—Methylprednisolone—multiple sclerosis	0.0011	0.0011	CcSEcCtD
Milnacipran—Convulsion—Methotrexate—multiple sclerosis	0.00109	0.00109	CcSEcCtD
Milnacipran—Dyspepsia—Prednisone—multiple sclerosis	0.00108	0.00108	CcSEcCtD
Milnacipran—Chest pain—Methotrexate—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Milnacipran—Decreased appetite—Prednisone—multiple sclerosis	0.00107	0.00107	CcSEcCtD
Milnacipran—Rash—Prednisolone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Dermatitis—Prednisolone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Fatigue—Prednisone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Headache—Prednisolone—multiple sclerosis	0.00106	0.00106	CcSEcCtD
Milnacipran—Constipation—Prednisone—multiple sclerosis	0.00105	0.00105	CcSEcCtD
Milnacipran—Dizziness—Triamcinolone—multiple sclerosis	0.00103	0.00103	CcSEcCtD
Milnacipran—Dizziness—Methylprednisolone—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Infection—Methotrexate—multiple sclerosis	0.00102	0.00102	CcSEcCtD
Milnacipran—Asthenia—Dexamethasone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Asthenia—Betamethasone—multiple sclerosis	0.00101	0.00101	CcSEcCtD
Milnacipran—Nervous system disorder—Methotrexate—multiple sclerosis	0.001	0.001	CcSEcCtD
Milnacipran—Thrombocytopenia—Methotrexate—multiple sclerosis	0.001	0.001	CcSEcCtD
Milnacipran—Gastrointestinal pain—Prednisone—multiple sclerosis	0.001	0.001	CcSEcCtD
Milnacipran—Nausea—Prednisolone—multiple sclerosis	0.001	0.001	CcSEcCtD
Milnacipran—Pruritus—Betamethasone—multiple sclerosis	0.000996	0.000996	CcSEcCtD
Milnacipran—Pruritus—Dexamethasone—multiple sclerosis	0.000996	0.000996	CcSEcCtD
Milnacipran—Skin disorder—Methotrexate—multiple sclerosis	0.000995	0.000995	CcSEcCtD
Milnacipran—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00099	0.00099	CcSEcCtD
Milnacipran—Vomiting—Triamcinolone—multiple sclerosis	0.000986	0.000986	CcSEcCtD
Milnacipran—Vomiting—Methylprednisolone—multiple sclerosis	0.000984	0.000984	CcSEcCtD
Milnacipran—Rash—Triamcinolone—multiple sclerosis	0.000978	0.000978	CcSEcCtD
Milnacipran—Dermatitis—Triamcinolone—multiple sclerosis	0.000977	0.000977	CcSEcCtD
Milnacipran—Anorexia—Methotrexate—multiple sclerosis	0.000977	0.000977	CcSEcCtD
Milnacipran—Rash—Methylprednisolone—multiple sclerosis	0.000976	0.000976	CcSEcCtD
Milnacipran—Dermatitis—Methylprednisolone—multiple sclerosis	0.000975	0.000975	CcSEcCtD
Milnacipran—Urticaria—Prednisone—multiple sclerosis	0.000974	0.000974	CcSEcCtD
Milnacipran—Headache—Triamcinolone—multiple sclerosis	0.000972	0.000972	CcSEcCtD
Milnacipran—Headache—Methylprednisolone—multiple sclerosis	0.00097	0.00097	CcSEcCtD
Milnacipran—Body temperature increased—Prednisone—multiple sclerosis	0.000969	0.000969	CcSEcCtD
Milnacipran—Abdominal pain—Prednisone—multiple sclerosis	0.000969	0.000969	CcSEcCtD
Milnacipran—Diarrhoea—Dexamethasone—multiple sclerosis	0.000963	0.000963	CcSEcCtD
Milnacipran—Diarrhoea—Betamethasone—multiple sclerosis	0.000963	0.000963	CcSEcCtD
Milnacipran—Hypotension—Methotrexate—multiple sclerosis	0.000957	0.000957	CcSEcCtD
Milnacipran—Dizziness—Betamethasone—multiple sclerosis	0.000931	0.000931	CcSEcCtD
Milnacipran—Dizziness—Dexamethasone—multiple sclerosis	0.000931	0.000931	CcSEcCtD
Milnacipran—Insomnia—Methotrexate—multiple sclerosis	0.000927	0.000927	CcSEcCtD
Milnacipran—Nausea—Triamcinolone—multiple sclerosis	0.000922	0.000922	CcSEcCtD
Milnacipran—Paraesthesia—Methotrexate—multiple sclerosis	0.00092	0.00092	CcSEcCtD
Milnacipran—Nausea—Methylprednisolone—multiple sclerosis	0.00092	0.00092	CcSEcCtD
Milnacipran—Dyspnoea—Methotrexate—multiple sclerosis	0.000913	0.000913	CcSEcCtD
Milnacipran—Somnolence—Methotrexate—multiple sclerosis	0.000911	0.000911	CcSEcCtD
Milnacipran—Hypersensitivity—Prednisone—multiple sclerosis	0.000903	0.000903	CcSEcCtD
Milnacipran—Dyspepsia—Methotrexate—multiple sclerosis	0.000902	0.000902	CcSEcCtD
Milnacipran—Vomiting—Dexamethasone—multiple sclerosis	0.000895	0.000895	CcSEcCtD
Milnacipran—Vomiting—Betamethasone—multiple sclerosis	0.000895	0.000895	CcSEcCtD
Milnacipran—Decreased appetite—Methotrexate—multiple sclerosis	0.000891	0.000891	CcSEcCtD
Milnacipran—Rash—Dexamethasone—multiple sclerosis	0.000888	0.000888	CcSEcCtD
Milnacipran—Rash—Betamethasone—multiple sclerosis	0.000888	0.000888	CcSEcCtD
Milnacipran—Dermatitis—Dexamethasone—multiple sclerosis	0.000887	0.000887	CcSEcCtD
Milnacipran—Dermatitis—Betamethasone—multiple sclerosis	0.000887	0.000887	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000885	0.000885	CcSEcCtD
Milnacipran—Fatigue—Methotrexate—multiple sclerosis	0.000883	0.000883	CcSEcCtD
Milnacipran—Headache—Betamethasone—multiple sclerosis	0.000882	0.000882	CcSEcCtD
Milnacipran—Headache—Dexamethasone—multiple sclerosis	0.000882	0.000882	CcSEcCtD
Milnacipran—Asthenia—Prednisone—multiple sclerosis	0.00088	0.00088	CcSEcCtD
Milnacipran—Pruritus—Prednisone—multiple sclerosis	0.000867	0.000867	CcSEcCtD
Milnacipran—Diarrhoea—Prednisone—multiple sclerosis	0.000839	0.000839	CcSEcCtD
Milnacipran—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000838	0.000838	CcSEcCtD
Milnacipran—Nausea—Betamethasone—multiple sclerosis	0.000836	0.000836	CcSEcCtD
Milnacipran—Nausea—Dexamethasone—multiple sclerosis	0.000836	0.000836	CcSEcCtD
Milnacipran—Urticaria—Methotrexate—multiple sclerosis	0.000814	0.000814	CcSEcCtD
Milnacipran—Dizziness—Prednisone—multiple sclerosis	0.000811	0.000811	CcSEcCtD
Milnacipran—Abdominal pain—Methotrexate—multiple sclerosis	0.00081	0.00081	CcSEcCtD
Milnacipran—Body temperature increased—Methotrexate—multiple sclerosis	0.00081	0.00081	CcSEcCtD
Milnacipran—Vomiting—Prednisone—multiple sclerosis	0.000779	0.000779	CcSEcCtD
Milnacipran—Rash—Prednisone—multiple sclerosis	0.000773	0.000773	CcSEcCtD
Milnacipran—Dermatitis—Prednisone—multiple sclerosis	0.000772	0.000772	CcSEcCtD
Milnacipran—Headache—Prednisone—multiple sclerosis	0.000768	0.000768	CcSEcCtD
Milnacipran—Hypersensitivity—Methotrexate—multiple sclerosis	0.000755	0.000755	CcSEcCtD
Milnacipran—Asthenia—Methotrexate—multiple sclerosis	0.000735	0.000735	CcSEcCtD
Milnacipran—Nausea—Prednisone—multiple sclerosis	0.000728	0.000728	CcSEcCtD
Milnacipran—Pruritus—Methotrexate—multiple sclerosis	0.000725	0.000725	CcSEcCtD
Milnacipran—Diarrhoea—Methotrexate—multiple sclerosis	0.000701	0.000701	CcSEcCtD
Milnacipran—Dizziness—Methotrexate—multiple sclerosis	0.000678	0.000678	CcSEcCtD
Milnacipran—Vomiting—Methotrexate—multiple sclerosis	0.000651	0.000651	CcSEcCtD
Milnacipran—Rash—Methotrexate—multiple sclerosis	0.000646	0.000646	CcSEcCtD
Milnacipran—Dermatitis—Methotrexate—multiple sclerosis	0.000645	0.000645	CcSEcCtD
Milnacipran—Headache—Methotrexate—multiple sclerosis	0.000642	0.000642	CcSEcCtD
Milnacipran—Nausea—Methotrexate—multiple sclerosis	0.000609	0.000609	CcSEcCtD
